Both Newfield Exploration and Pioneer Natural Resources are trading near trendline resistance, and a...
Update Borg Warner (BWA)
08/02/2011 1:07 pm EST
On July 28 the company reported second quarter earnings of $1.12 a share (excluding one-time items), or 13 cents above Wall Street projections. Revenue climbed 28% from the second quarter of 2010 to $1.82 billion. Wall Street had been looking for revenue of $1.74 billion.
And looking forward the company raised guidance for 2011 to $4.25 to $4.45 a share from the prior projection of $3.85 to $4.15 a share. Revenue will grow by 25% to 28% for the year to a range of $7.1 billion to 7.2 billion.
The best performance this quarter came from the engine unit where sales climbed 28% from the second quarter of 2010. Margins of 15.2% were above Wall Street estimates due to strong sales of engine timing systems in North America and China and on continued growth in turbochargers.
But the company also showed good progress in fixing its problems in Europe where the company has been working to restructure capacity and raise margins. Margins in the European drive train unit increased this quarter to 7.4% from 6.6% in the first quarter.
After Borg Warner’s great fourth quarter of 2010, I’d recommended this stock in January with a target price of $82 a share by October 2011. The stock hit that price in July, just a bit ahead of schedule.
Borg Warner has been a member of my Jubak’s Picks portfolio http://jubakpicks.com/ since January 2011. I think Borg Warner is on track to produce earnings of $5.50 a share in 2012 and that would take the stock up to my new target price, as of August 2, of $98 a share by July 2012. That would be roughly a 27% gain from the August 2 price.
Full disclosure: I don’t own shares of Borg Warner in my personal portfolio. The mutual fund I manage, Jubak Global Equity Fund http://jubakfund.com/ , may or may not now own positions in any stock mentioned in this post. The fund did own shares of Borg Warner at the end of March. For a full list of the stocks in the fund as of the end of March see the fund’s portfolio at http://jubakfund.com/about-the-fund/holdings/
Related Articles on STOCKS
Anavex (AVXL) is a biopharmaceutical company dedicated to the development of novel drug candidates t...
Back in October we suggested investors keep an open mind with respect to retailers, which had been b...
Oil companies typically come into favor in mid-December and remain so until late April or early May ...